These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8726036)

  • 21. [Antimicrobial susceptibility surveillance of Streptococcus pneumoniae and Haemophilus influenzae isolates to cefteram and other antimicrobial drugs during January 2003 to July 2004].
    Matsuzaki K; Watabe E; Furuki A; Kanayama A; Hasegawa M; Sato Y; Kobayashi I
    Jpn J Antibiot; 2004 Dec; 57(6):475-80. PubMed ID: 15747585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.
    van Zyl L; le Roux JG; LaFata JA; Volk RS; Palo WA; Flamm R; Hom RC
    Clin Ther; 2002 Nov; 24(11):1840-53. PubMed ID: 12501878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surveillance of susceptibility of clinical isolates to cefpodoxime between 2000 and 2003].
    Abe T; Koga T; Sato Y; Ito K; Tochikawa Y
    Jpn J Antibiot; 2005 Jun; 58(3):259-82. PubMed ID: 16161753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
    Doern GV; Vautour R
    Diagn Microbiol Infect Dis; 1992; 15(7):633-40. PubMed ID: 1424521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial activity of eight cephalosporins against Haemophilus influenzae and Streptococcus pneumoniae.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    J Antimicrob Chemother; 1976 Mar; 2(1):55-9. PubMed ID: 6415
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia.
    San Pedro GS; Cammarata SK; Oliphant TH; Todisco T;
    Scand J Infect Dis; 2002; 34(10):720-8. PubMed ID: 12477321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibacterial activity of cefpodoxime in vitro.
    Liu YC; Huang WK; Cheng DL
    Chemotherapy; 1997; 43(1):21-6. PubMed ID: 8996737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].
    Matsuzaki K; Yoshimori K; Shikano M; Watabe E; Sato Y; Hasegawa M; Kobayashi I; Yamanaka N
    Jpn J Antibiot; 2003 Jun; 56(3):171-9. PubMed ID: 12942788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic susceptibility of type b Haemophilus influenzae and Streptococcus pneumoniae, and antibiotic concentration in cerebrospinal fluid.
    Fujita K; Zhang DH; Sakata H; Murono K; Kakehashi H; Yoshioka H
    Acta Paediatr Jpn; 1990 Apr; 32(2):132-8. PubMed ID: 2116062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model.
    Smith PF; Tsuji B; Booker BM; Forrest A; Bajic S; Kelchlin P; Bhavnani SM; Jones RN; Ambrose PG
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):379-86. PubMed ID: 16930921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamic activity of five oral cephalosporins against Haemophilus influenzae.
    Stein GE; Schooley S; Walker RD; Strenkoski-Nix L
    Pharmacotherapy; 1997; 17(2):235-41. PubMed ID: 9085313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases.
    Bauernfeind A
    Diagn Microbiol Infect Dis; 1991; 14(1):89-92. PubMed ID: 2013215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
    Wise R; Andrews JM; Ashby JP; Thornber D
    J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis.
    Fernández-Roblas R; López JC; Ramos JM; Gimeno M; Coronel P; Soriano F
    J Antimicrob Chemother; 1996 May; 37(5):1038-9. PubMed ID: 8737159
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial activity of LB10827, a new orally administered cephalosporin, tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
    Deshpande LM; Beach ML; Mutnick AH; Jones RN
    Clin Microbiol Infect; 2003 Aug; 9(8):893-6. PubMed ID: 14616716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.